The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful responses to a disease.

A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by Weill Cornell Medicine. Researchers found that only 1.6% of 546 Ugandan patients had mutations linked to lenacapavir resistance,

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful responses to a disease.

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world’s most successful responses to a disease

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful responses to a disease. For two decades, the American people

Florence Makumene held a plastic container of HIV medication and wondered if it would be her last as fears swelled of a return to a time decades ago when millions across sub-Saharan Africa died of AIDS.

Millions of children in Africa rely on funding from the United States for HIV care or testing — support that was threatened last month when President Donald J. Trump froze foreign aid spending after taking office.

In the rural villages of South Africa, U.S. President Donald Trump’s sudden freeze on foreign aid impacts hundreds of thousands of HIV patients. The freeze has affected the President’s Emergency

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

At a rural village in South Africa’s KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the

Pandemonium broke out in the aid world. The US accounts for roughly 42% of global humanitarian spending. In some areas such as HIV-AIDs prevention and treatment, its $5.4bn (2024) in annual spending (97% for overseas programs) is over 25% of the global budget.